Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2828 of 5804
-
Virtual pain coaching shows promise for breast cancer patients in rural clinics
Symptom relief CompletedThe efficacy of a mobile health (mHealth) behavioral cancer pain intervention designed to decrease pain and disability for breast cancer patients in medically underserved areas has not been investigated. The long-term goal of this work is to use mHealth technologies to facilitate…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Scientists try to personalize heated chemo for stomach cancers
Knowledge-focused Recruiting nowBackground: Cytoreductive surgery (CRS) removes tumors in the abdomen. HIPEC is hyperthermic (heated) chemotherapy that washes the inside of the abdomen. CRS with HIPEC may help people with peritoneal carcinomatosis. These are tumors that have spread to the lining of the abdomen…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
New cancer drug trial hopes to reawaken immune cells against tumors
Disease control TerminatedImmune therapies work with the body's immune system to treat a number of cancers. They work with T-cells, a type of white blood cell, to target and attack specific tumors. However, some tumors can become resistant to attack by T-cells over time. They do this by sending "off" sign…
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Arm shot may boost walking after stroke
Symptom relief Recruiting nowThe aim of the present pilot study is to evaluate the association between change in gait related mobility in ambulatory male and female adult hemiparetic patients before and 4-6-weeks after Xeomin® injection into the upper limb, using two standardized tests of physical function i…
Phase: PHASE4 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Smart watches and scales could transform cancer recovery
Knowledge-focused OngoingThis study aims to see whether an at-home monitoring program that collects health, symptoms, and quality of life data in real-time can be included as part of the care of surgery patients in order to provide better recovery. Patient-generated health data (weight, temperature, oxyg…
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Smart boots could save feet: new study tests wearable tech for diabetic ulcers
Symptom relief Recruiting nowThe purpose of this study is to help people with diabetes who develop neuropathic diabetic foot ulcers (DFUs). These ulcers, or sores, if left untreated can increase the chance of amputation. Part of the treatment is to have the person wear a diabetic shoe or boot to help their f…
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
New hope for depressed pregnant smokers: mood program aims to help quit for good
Symptom relief OngoingThis study evaluates a mood management and health and wellness smoking cessation intervention for depressed pregnant smokers during and after birth. This study may help pregnant smokers who are experiencing depression quit smoking and stay smoke-free after their babies are born.
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Can a blood injection stop hernias from returning?
Disease control OngoingRationale: Gastroesophageal reflux disease (GERD) is a common disease caused by a dysfunctional lower esophageal sphincter and an abnormal esophageal hiatus or hiatal hernia. Approximately 30% of large hiatal hernias will recur after surgery, in part due to weak connective tissue…
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New Eye-Tracking app could spot MS progression early
Knowledge-focused Recruiting nowThis study aims to develop and validate a sensitive and non-invasive eye-tracking software application. This study will obtain participant responses to brief cognitive tests designed to evaluate several key functions known to be affected by MS and non-invasive eye movement measu…
Sponsor: Innodem Neurosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Phone app could help pregnant women control diabetes in nepal
Disease control CompletedAdequate control and management of gestational diabetes mellitus (GDM) during pregnancy is critical to mitigate its short- and long-term health consequences in women and their children and may serve as a key strategy to curb the escalating type 2 diabetes epidemic in low- and mid…
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Belly fat in midlife linked to Alzheimer's brain changes?
Knowledge-focused Recruiting nowHigh body fat at midlife, as evidenced by overweight or obese body mass index (BMI), is increasingly understood as a risk factor for Alzheimer's disease. However, the underlying processes and mechanisms that may underlie this risk remains unknown. With this project, the Investiga…
Sponsor: Cyrus A Raji • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Vitamin a derivative combined with immunotherapy shows promise in early lung cancer trial
Disease control CompletedThis phase Ib trial is to find out the best dose and side effects of all-trans retinoic acid (ATRA) and atezolizumab in treating patients with non-small cell lung cancer that has come back (recurrent) or has spread to other places in the body (metastatic). All-trans retinoic acid…
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Experimental combo targets lung cancer that resists immunotherapy
Disease control TerminatedThis is a Phase I study evaluating the safety of atezolizumab in combination with ADV/IL-12 gene therapy in patients with metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on first-line immunotherapy with or without chemotherapy.
Phase: PHASE1 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Tailored Alzheimer's care cuts hospital visits, study finds
Symptom relief CompletedThe present project propose to study the effectiveness of a personalized care management of psycho-behavioral symptoms based on an evidence-based standardized assessment to identify and understand the underlying causes of psycho-behavioral symptoms followed by a personalized inte…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Nose decolonization may cut infection risk in hip and knee replacements
Symptom relief CompletedLower limb joint replacement surgery is one of the most prevalent globally. In our center, more than 400 lower limb arthroplasties (LLA) are performed annually. Developing a Surgical Site Infection (SSI) after (LLA) increases morbidity, mortality and healthcare costs. Staphylococ…
Sponsor: Corporacion Parc Tauli • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New drug cocktail shows promise for advanced kidney cancer in early trial
Disease control OngoingThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic profiles, and preliminary efficacy of belzutifan as monotherapy followed by belzutifan+lenvatinib combination therapy, as well as belzutifan combined with lenvatinib and pembrol…
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Scientists use magnetic pulses to map hallucinations in the brain
Knowledge-focused Recruiting nowThis study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study how hallucinations work in schizophrenia. TMS is a noninvasive way of stimulating the brain, using a magnetic field to change activity in the brain. The magnetic field is produced by …
Phase: NA • Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Can virtual reality boost brain power in movement disorders?
Symptom relief CompletedMild cognitive impairment associated with movement disorders occurs in up to one third of patients in early stages of the disease, and confers an increased risk of developing dementia. Non-pharmacological interventions to improve cognition have so far been based on computer-based…
Phase: NA • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Ultrasound-Guided ventilation may shorten time on ventilator for ARDS patients
Disease control Recruiting nowARDS is characterized by a diffuse, bilateral, extensive alveolar-interstitial infiltrate related to damage to the alveolar membrane. Studies of lung morphology assessed by CT scan have shown 2 types of ARDS. When the loss of ventilation is posterior and caudal, and the pulmonar…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Brain training with magnetic pulses may restore arm function after spinal cord injury
Symptom relief Recruiting nowThe purpose of this study is to examine the relationship between common clinical assessments and measurements of the function of brain-spinal cord-muscle connections, and to examine the effects of training a brain-spinal cord-muscle response in individuals with incomplete spinal …
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC